Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Share-based Compensation (2020 - 2025)

Sotera Health has reported Share-based Compensation over the past 6 years, most recently at $7.6 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $7.6 million for Q4 2025, down 7.07% from a year ago — trailing twelve months through Dec 2025 was $30.9 million (down 16.04% YoY), and the annual figure for FY2025 was $30.9 million, down 16.04%.
  • Share-based Compensation for Q4 2025 was $7.6 million at Sotera Health, down from $7.9 million in the prior quarter.
  • Over the last five years, Share-based Compensation for SHC hit a ceiling of $10.2 million in Q2 2024 and a floor of $3.4 million in Q4 2021.
  • Median Share-based Compensation over the past 5 years was $7.4 million (2023), compared with a mean of $6.7 million.
  • Peak annual rise in Share-based Compensation hit 293.67% in 2021, while the deepest fall reached 51.48% in 2021.
  • Sotera Health's Share-based Compensation stood at $3.4 million in 2021, then skyrocketed by 85.03% to $6.3 million in 2022, then soared by 31.14% to $8.2 million in 2023, then dropped by 0.73% to $8.1 million in 2024, then fell by 7.07% to $7.6 million in 2025.
  • The last three reported values for Share-based Compensation were $7.6 million (Q4 2025), $7.9 million (Q3 2025), and $8.1 million (Q2 2025) per Business Quant data.